Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,837,916
+$248,852 QoQ
Shares Held
121,799
-6.0% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Gotham Asset Management, LLC holds $380,034,529 across 45 Biotechnology names. INVA ranks #15 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
82,846 | $64,010,133 | |
| 2 | INCY |
Incyte Corp
|
676,670 | $63,688,180 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
746,841 | $48,268,333 | |
| 4 | EXEL |
Exelixis, Inc.
|
919,870 | $39,453,224 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
1,416,091 | $39,225,720 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
91,626 | $17,321,895 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,710 | $14,462,327 | |
| 8 | CAI |
Caris Life Sciences, Inc.
|
744,426 | $13,310,336 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,837,916 | 121,799 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,589,064 | 129,518 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,057,614 | 112,746 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,695,716 | 84,406 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,181,387 | 65,162 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $761,647 | 43,899 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $617,668 | 31,987 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $499,675 | 30,468 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $532,851 | 34,964 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $394,487 | 24,594 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $236,430 | 18,201 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $203,934 | 16,020 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $300,870 | 26,744 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $528,463 | 39,884 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $489,663 | 42,176 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $890,603 | 60,339 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $981,451 | 50,721 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $955,822 | 55,410 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $641,480 | 38,389 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $474,901 | 35,414 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $486,639 | 40,723 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,040,041 | 83,942 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $837,337 | 80,128 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $803,947 | 57,507 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,120,375 | 95,270 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||